CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host
its fourth quarter 2010 investor update conference call and webcast at
8:30 a.m. Eastern Time on Thursday, March 3, 2011. Individuals
interested in participating in the call should dial (888) 206-4836 (U.S.
and Canada) or (913) 312-0679 (international) using conference ID number
9353790. To access the webcast, please visit the Investors section of
Ironwood's website at www.ironwoodpharma.com
at least 15 minutes prior to the start of the call to ensure adequate
time for any software downloads that may be required.
The call will be available for replay via telephone starting March 3,
2011, at approximately 11:30 a.m. Eastern Time, running through 11:59
p.m. Eastern Time on March 17, 2011. To listen to the replay, dial (888)
203-1112 (U.S. and Canada) or (719) 457-0820 (international) using
conference ID number 9353790. The archived webcast will be available on
Ironwood's website for 14 days beginning approximately one hour after
the call.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial
pharmaceutical company dedicated to the art and science of great
drugmaking. Linaclotide, Ironwood's GC‐C agonist, is being evaluated in
a confirmatory Phase 3 program for the treatment of irritable bowel
syndrome with constipation (IBS‐C) and chronic constipation. Ironwood
also has a growing pipeline of additional drug candidates in earlier
stages of development. Ironwood is located in Cambridge, Mass.
Ironwood Pharmaceuticals, Inc.
Susan Brady, 617-621-8304
Corporate
Communications
sbrady@ironwoodpharma.com
Source: Ironwood Pharmaceuticals, Inc.
News Provided by Acquire Media